Seer Appoints Former Biologos CEO Anthony Bazarko as Chief Commercial Officer
SEER•Seer has appointed Anthony Bazarko as Chief Commercial Officer to lead Sales, Marketing and Customer Experience and accelerate adoption of its Proteograph Product Suite. Bazarko brings more than two decades of global commercial leadership in life sciences, having led go-to-market strategies at Biologos and Specific Diagnostics that drove major acquisitions.
1. Seer Appoints Anthony Bazarko as CCO
Seer has named Anthony Bazarko as Chief Commercial Officer to oversee its Sales, Marketing and Customer Experience divisions. He will be responsible for executing global commercial strategies and accelerating market penetration of the Proteograph Product Suite.
2. Bazarko’s Commercial Leadership Track Record
Bazarko brings over twenty years of experience in life sciences and biotechnology, including roles as President and CEO of Biologos and Chief Commercial Officer at Specific Diagnostics. He previously led North American commercial operations at Danaher’s Leica Biosystems and strategic affairs at Roche Diagnostics.
3. Growth and Proteograph Suite Expansion Strategy
His appointment is expected to strengthen Seer’s go-to-market execution and expand adoption of its deep proteomics platform. Seer aims to leverage his track record of driving revenue growth and facilitating major acquisitions to accelerate commercial momentum.
